Search Team

Search by Last Name
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
 
 

Life Sciences

full industries list
Life Sciences Image
News
Events
Litigation Blog
Hatch-Waxman

Fish attorneys have served as leading advisors to pioneers in the pharmaceutical, biotechnology, and life sciences fields for more than a century. For three consecutive years, we have been named the top US law firm for life sciences and biotechnology IP work by Managing Intellectual Property. Clients choose Fish because of the technical and scientific expertise of our internationally recognized attorneys.

Large and small companies, along with academic and research institutions, turn to Fish’s team to protect their most valuable innovations. We offer biotechnology and pharmaceutical clients services that include:

Our industry-leading litigation practice regularly represents the world’s largest branded pharmaceutical companies in high-stakes, high-risk litigation. Drug makers trust our litigators to handle their blockbuster Hatch-Waxman, BPCIA, and competitor litigation matters because they possess the unique combination of technical, legal, and industry expertise necessary for success.

Examples of our biotechnology and pharmaceutical work include:

  • Patenting groundbreaking life sciences innovations, including tissue engineering, therapeutic agents and methods, antibodies, and genetically engineered animals
  • Gaining FDA approvals for small molecule drugs and biologics, including gene and cell therapies, antibiotics, immunologics, and anti-anxiety medications
  • Conducting IP due diligence on billions of dollars in deal value for pharmaceutical investments, mergers, and acquisitions
  • Representing dozens of biotechnology and pharmaceutical clients in patent infringement litigation
  • Litigating ANDA cases on behalf of branded pharmaceuticals
  • Representing biotechnology and pharmaceutical companies in post-grant proceedings at the PTAB, as well as coordinating post-grant and district court litigation strategies

Notable Wins

Fish Wins Federal Circuit Affirmance of Reversal of $200 Million Damages Against Gilead

Fish won a unanimous Federal Circuit opinion today that affirmed its June 2016 post-trial wipe-out of a $200 million jury verdict against client Gilead Sciences, Inc. after proving Merck had forfeited its right to assert its hepatitis C drug patents against Gilead because of litigation and business misconduct constituting “unclean hands.”

Read more about this precedential opinion here and here.

Fish Wipes Out $2.5B Patent Verdict Against Gilead Sciences

Fish & Richardson won a motion for Judgment as a Matter of Law (JMOL) that reversed a $2.5 billion jury verdict against its client Gilead Sciences Inc. in federal court in Delaware.

Read about this historic win here and here.

Recent Webinars

2021

2020

2019

2018

Mayo/Myriad Tracker

Search Fish Team

Search by Letter
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
No matches
Life Sciences

Life Sciences Team

What's Trending in Life Sciences

Filter by
Event
July 22nd, 2021 | 1:30 pm EDT
Webinar | Biosimilars Mid-Year Review
Webinar
Event
June 23rd, 2021 | 2:45 pm EDT
Federal Circuit Bar Association’s 2021 Bench & Bar® Conference
Speaking Engagement
Conference/Convention
Sponsorship
Event
June 24th, 2021 | 1:10 pm EDT
LSX Biotech Startup CEO Forum
Speaking Engagement
Sponsorship
Event
June 23rd, 2021 | 12:00 pm EDT
The Nexus of IP and R&D: Applying Insights to Accelerate Innovation
Speaking Engagement
Webinar
Blog
June 4, 2021
Users of Research Tools Take Note
Author: Brian D. Coggio
Event
June 9th, 2021 | 5:00 am EDT
Pharma Intelligence Webinar | Designing the Deal
Speaking Engagement
Sponsorship
News
May 21, 2021
Philadelphia Business Journal Recognizes Fish & Richardson Principal Nitika Gupta Fiorella in its 2021 “40 Under 40” List
Recognition
News
Event
June 3rd, 2021 | 1:30 pm EDT
Webinar | Hatch-Waxman: How to Prepare for the Paragraph IV Letter
Webinar
Event
May 5th, 2021 | 11:00 am EDT
One Nucleus BioWednesday: Opportunities for UK Life Sciences - A US Perspective
Speaking Engagement
Sponsorship
News
April 22, 2021
Fish & Richardson Names Betsy Flanagan as Managing Principal of Twin Cities Office
Announcements
News
Event
April 26th, 2021 | 7:45 am PDT
Life Science Washington: World IP Day 2021
Speaking Engagement
Sponsorship
News
April 21, 2021
Daily Journal Recognizes Fish & Richardson Principals Juanita Brooks and Jonathan Singer as 2021 “Top Intellectual Property Lawyers”
Recognition
News
load more topics